|
|
|
|
|
|
|
|
|
|
|
|
Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the appropriate link below.
Alzheimer's Disease Research
Macular Degeneration Research
National Glaucoma Research
This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
|
|
|
|
Open Award Programs
In this section, you will find information on:
Active Annual Award Programs
Alzheimer's Disease Research
|
The ADR program offers three types of awards:
- Standard Awards
Award Amount: $400,000
Duration: 3 yrs
Deadline for full application submission:
October 22nd, 2008*
The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies.
- Pilot Awards
Award Amount: $150,000
Duration: 2 Yrs
Deadline for full application submission:
October 22nd, 2008*
Pilot awards are designed to take a highly innovative proposal with modest preliminary data and give investigators the opportunity to prove their ideas. These awards are typically described as being ‘high risk – high reward’. They are often given to investigators who need funding to demonstrate the validity of a very focused hypothesis.
- Postdoctoral Fellowship Awards
Award Amount: $100,000
Duration: 2 yrs
Deadline for full application submission:
October 22nd, 2008*
Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards are meant to fund projects in an established laboratory that will serve as the basis for the applicant's own independent research career. |
The discovery and development of drugs is a very expensive and time-consuming process. For academic researchers in this field, the lack of sufficient funding is a particularly great hurdle which often severely limits research progress …. AHAF thus serve(s) a vital role, not only in providing much-needed funds for translational research, but also in connecting researchers with different areas of expertise and enabling them to bring together their knowledge and experience in innovative ways. For these reasons we are sincerely grateful and very much indebted to the AHAF and its donors for their support of our research into new treatments for Alzheimer’s disease.
- Donald Weaver, Ph.D. |
Back to Top
Macular Degeneration Research
- Standard Award
Maximum award value: $100,000
Maximum duration: 2 years
Letter of Intent Deadline:
July 10, 2008*
Deadline for Invited Full Submissions:
November 3, 2008*
The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies. |
The AHAF funding has been essential in enabling a large, collaborative research study on the genetics of AMD. We have been able to use this grant to prepare for a much larger project by enhancing the value of our established patient resources and ensuring that we have funding for the data analyses. Essentially, the AHAF and other funds available to us at this time have been leveraged into a $3.5 million genotyping project funded by the National Eye Institute. This project is expected to revolutionize our understanding of AMD by helping identify many of the remaining and unknown genetic risks for AMD.
- Albert O. Edwards, M.D., Ph.D. |
Back to Top
National Glaucoma Research
- Standard Awards
Award Amount: $100,000
Maximun Duration: 2 yrs
Deadline for full application submission:
October 27nd, 2008*
The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies. |
We appreciate very much the support from AHAF and wish to express our reverence and high esteem to the donors, administrators and reviewers. The award we received from National Glaucoma Research and the AHAF has been a very significant factor in advancing our knowledge of retinal stem cells and their use in therapy for retinal diseases. Receiving this award came a significant time in our research as we are now able to direct our knowledge from years of basic research to actually rescue blindness in mice.
-Derek Van der Kooy, Ph.D. |
Back to Top
Special Awards Programs
Occasionally, AHAF offers award programs outside of the traditional annual awards. However, no special award programs are open at this time.
Back to Top
*All deadlines are considered to be 11:59 PM EST (Washington, D.C.) on the date of the deadline.
Last Reviewed On: 09/26/08
|
|
|
|
